• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » St. Jude Medical settles Riata, shareholder suits for $64m

St. Jude Medical settles Riata, shareholder suits for $64m

February 27, 2015 By Brad Perriello

St. Jude Medical settles Riata, shareholder lawsuits for $64m

St. Jude Medical (NYSE:STJ) said it settled a raft of product liability lawsuits filed over its Riata and Riata ST defibrillator leads and agreed with shareholders to close out a class action lawsuit brought over its 3rd-quarter 2009 results.

Taken together the settlements are worth nearly $64.3 million, including $14.3 million for the Riata cases and $50 million for the shareholders lawsuit, according to a regulatory filing.

St. Jude pulled the silicone-coated Riata and Riata ST leads in 2010 after finding that some of the internal conductors had worn through their insulation, a failure that could result in patients receiving unwanted shocks. In November 2011 the company warned that the Riata leads appeared to fail more frequently than previously reported, leading to a Class I recall from the FDA.

Yesterday the company said it agreed to settle all but 3 of the nearly 1,000 Riata cases it’s facing, without admitting any liability, and said it put aside $15 million during Q4 2014 to cover the deal.

"Patient safety is St. Jude Medical’s highest priority. The company remains dedicated to developing technology and products that save and improve the lives of patients around the world," St. Jude said in a statement. "In the interest of patient safety and continued transparency surrounding data from the company’s silicone-only leads, St. Jude Medical continues to communicate regularly with physicians about long-term performance of implanted Riata leads through a semi-annual product performance report and through www.riatacommunication.com, a dedicated resource for providing the latest information on Riata leads."

St. Jude also said it agreed to pay $50 million to settle a lawsuit filed in March 2010 alleging that it concealed evidence of slowing demand and lower orders for its cardiac rhythm management products before it lowered its guidance after the 3rd quarter of 2009. St. Jude moved to have the suit tossed in 2013, arguing that the plaintiffs "cannot prove the allegations of ‘fraud’ in their complaint."

Yesterday the company said it agreed to settle the class action case, agreeing to a $50 million payment pending preliminary approval by the U.S. District Court for Minnesota, where a hearing is slated for March 12. St. Jude said it recognized probable insurance recoveries of $30 million for case and "intends to pursue collection of additional insurance recoveries from certain of its insurance carriers."

Filed Under: Legal News, News Well, Product Liability, Wall Street Beat Tagged With: stjudemedical

More recent news

  • Imperative Care has positive stroke treatment study results
  • Medtronic enrolls first patient in study for Onyx liquid embolic system
  • Intuitive demonstrates remote telesurgery capabilities with da Vinci 5
  • BD issues voluntary recall on certain Alaris infusion pump modules
  • CVRx announces Medicare win for Barostim therapy

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy